Rule 144 notice: planned sale of 38869 UUUU common shares (UUUU)

Rhea-AI Filing Summary

An affiliate of the issuer plans to sell 38869 shares of common stock through broker Charles Schwab Corp. The planned sale has an aggregate market value of $554271.94, with 237286768 shares of the class outstanding, and is expected to occur around 12/15/2025 on the NYSE.

The shares to be sold were acquired through restricted stock awards from the issuer and several open market purchases between 2019 and 2022, including 3211 shares from a restricted stock award on 01/27/2022, 21658 shares from a restricted stock award on 01/27/2021, and 8000 shares bought on 12/08/2022. The person filing also sold 38739 common shares during the past three months, on 11/17/2025, for gross proceeds of $588736.94.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab Corp. 3000 Schwab Way Westlake TX 76262	38869	554271.94	237286768	12/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/27/2022	Restricted Stock Award	Issuer			3211	01/27/2022	Equity Compensation
Common	01/27/2021	Restricted Stock Award	Issuer			21658	01/27/2021	Equity Compensation
Common	12/08/2022	Open Market Purchase	N/a			8000	12/08/2022	Cash
Common	01/03/2020	Open Market Purchase	N/A			2000	01/03/2020	Cash
Common	01/02/2020	Open Market Purchase	N/A			1000	01/03/2020	Cash
Common	07/08/2019	Open Market Purchase	N/A			2000	07/08/2020	Cash
Common	03/29/2019	Open Market Purchase	N/A			1000	03/29/2019	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Alexander Morrison 225 UNION BLVD., SUITE 600, Lakewood CO 80228	Common	11/17/2025	38739	588736.94

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing reveal about planned sales of UUUU common stock?

The notice states that an affiliate of the issuer intends to sell 38869 shares of UUUU common stock through Charles Schwab Corp., with an aggregate market value of $554271.94, around 12/15/2025 on the NYSE.

How many shares of UUUU common stock are outstanding in this Form 144?

The filing reports that there are 237286768 shares of the relevant class of UUUU common stock outstanding.

How were the UUUU shares being sold under this Form 144 acquired?

The shares were acquired through a mix of restricted stock awards from the issuer and open market purchases between 2019 and 2022, including 3211 shares awarded on 01/27/2022, 21658 shares awarded on 01/27/2021, and 8000 shares purchased on 12/08/2022.

What prior sales of UUUU shares during the last three months does the Form 144 disclose?

The filing shows that Alexander Morrison sold 38739 UUUU common shares on 11/17/2025, generating gross proceeds of $588736.94.

Which broker and exchange are involved in the planned UUUU share sale?

The planned sale will be executed through Charles Schwab Corp., 3000 Schwab Way, Westlake, TX 76262, and the common stock is listed on the NYSE.

What does the Form 144 representation say about undisclosed material information?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer's current or prospective operations that has not been publicly disclosed.